Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Active Pharmaceutical Ingredients (API) and Pharmaceutical Excipients Market Research Report 2022-2029 – Increasing Scope of HPAPI and Advanced Next Generation Biologics Market

Published

on

<!– Name:DistributionId Value:8782271 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1026737 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:671ebbfb-03eb-4d8e-97bf-c14b593ce0b7 –>

Dublin, March 06, 2023 (GLOBE NEWSWIRE) — The “Active Pharmaceutical Ingredients (API) Global Market – Forecast To 2029” & “Pharmaceutical Excipients Global Market – Forecast To 2029” report has been added to ResearchAndMarkets.com’s offering.

Generally, each drug made up of two components that are API and excipients, having curative activity. APIs are often known as bulk pharmaceuticals and most of all APIs are in powder form. Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized based on chemical synthesis, fermentation, biotechnological methods or enhanced from the natural source.

North America accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Growing pharma R&D expenditure, increasing development of new drugs over the time, increasing approval of generics and biosimilars, growing biopharmaceutical drugs pipelines, presence of number of API manufacturing facilities for all regulated drug products, increasing scope of highly potent drugs, government support to expand the domestic pharmaceutical manufacturing facilities and increase in the prevalence of infectious diseases, cancer, central nervous system associated diseases, cardiac disease, and musculoskeletal disorder are some of the major diseases that are driving the market growth. Asia-Pacific is the fastest-growing region with a high single digit CAGR from 2022 to 2029.

The factors such as increasing generic pharmaceuticals and vaccines production, number of pharma companies with a strong network of manufacturing facilities, increasing outsourcing with number of CMO’s and expanding manufacturing facilities, increasing development of new pharma and biopharma drugs, growing biotech R&D investment, presence of number of innovative biotech startups, presence of dedicated departments to support biotechnology research, increasing government investment to support the pharma and biotech industry, low labor cost, and increased prevalence of infectious and other chronic diseases are driving the market growth.

Some of the key players of Active pharmaceutical Ingredient (API) market are

  • Catalent Inc.
  • Divis Laboratories
  • Euroapi
  • Lonza Group Ltd.
  • Pfizer Inc.
  • Samsung Biologics Co. Ltd.
  • Teva Pharmaceutical Industries Limited.
  • Thermo Fisher Scientific Inc
  • Wuxi Apptec Co. Ltd.
  • Wuxi Biologics (Cayman) Inc.

Key Topics Covered:

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increasing Incidence and Prevalence of Chronic, Communicable and Autoimmune Diseases
3.3.1.2 Adoption of Biologics in Disease Management and Increasing Regulatory Approvals
3.3.1.3 Increasing Investment in Research and Development (R&D) and Expansion of Manufacturing Facilities
3.3.1.4 Patent Expiration of Major Drugs
3.3.1.5 Increasing Scope of Hpapi and Advanced Next Generation Biologics Market
3.3.1.6 Increasing Trend of Outsourcing and Adoption in Emerging Market
3.3.1.7 Increase in the Geriatric Population
3.3.2 Restraints and Threats
3.3.2.1 Contamination of API
3.3.2.2 High Cost for Manufacturing Apis
3.3.2.3 a Requirement of Highly Skilled Technicians
3.3.2.4 Pierce Competition Between API Players
3.3.2.5 Presence of Alternatives
3.3.2.6 Stringent Regulatory Policies and Environmental Concerns
3.4 Regulatory Affairs
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Automation and Control
3.5.3 Continuous Flow Manufacturing
3.5.4 Cryogenic Technology
3.5.5 Single – Use System (Sus)
3.5.6 Artificial Intelligence in API Manufacturing
3.5.7 Chemistry in Water
3.5.8 M-Rna Technology in Vaccine Manufacturing
3.5.9 Advancements in Hpapi Manufacturing
3.6 Porter’s Five Force Analysis
3.7 Supply Chain Analysis
3.8 Market Share Analysis
3.9 Fda Approved API Manufacturing Units
3.10 Pharmaceutical API Production Volume
3.11 Patent Expiry and Anda Approvals
3.12 Drug Master Filing (Dmf)
3.13 Repurposed Drugs for COVID-19 Treatment
3.14 Acquisition, Merger, and Expansions in API Manufacturing
3.15 Selected Top Selling API
3.16 API Manufacturers Revenue and Capabilities Table

4 API Global Market, Based on Synthesis
4.1 Introduction
4.2 Synthetic API
4.2.1 Synthetic API Based on Customer Base
4.3 Biotech API
4.3.1 Antibodies
4.3.2 Recombinant Proteins
4.3.3 Vaccines
4.3.4 Gene Therapy
4.3.5 Cell Therapy
4.3.6 Other Biotech API
4.3.7 Biotech API Based on Customer Base
4.3.7.1 Biologic API
4.3.7.2 Biosimilar API
4.4 Hpapi
4.4.1 Hpapi Based on Customer Base

5 API Global Market, Based on Business Type
5.1 Introduction
5.2 Captive API Based on Type
5.2.1 Branded Captive API
5.2.2 Generic Captive API
5.3 Merchant API Based on Type
5.3.1 Branded Merchant API
5.3.2 Generic Merchant API

6 API Global Market, Based on Application
6.1 Introduction
6.2 Infectious Diseases
6.3 Oncology
6.4 Cardiovascular Diseases
6.5 Central Nervous System
6.6 Pulmonary Diseases
6.7 Gastrointestinal Diseases
6.8 Endocrine Diseases
6.9 Metabolic Disorders
6.10 Genitourinary Diseases
6.11 Musculoskeletal Diseases
6.12 Other Applications (Nephrology, Hepatology, Opthalmology, Dental, Pain Management, Dermatology,Ent Etc.,)

7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest of North America
7.3 Europe
7.3.1 Italy
7.3.2 Germany
7.3.3 France
7.3.4 Rest of Europe
7.4 APAC
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of APAC
7.5 RoW
7.5.1 Brazil
7.5.2 Rest of Latam
7.5.3 Middle East & Others

8 Competitive Landscape
8.1 Introduction
8.2 Collaboration, Partnership and Agreement
8.3 Expansion
8.4 Approvals
8.5 New Product, Service and Technology Launch
8.6 Acquisition
8.7 Others

9 Major Companies
9.1 Overview
9.2 Financials
9.3 Service Portfolio
9.4 Key Developments
9.5 Business Strategy
9.6 SWOT Analysis

Companies Mentioned

  • Aarti Drugs Ltd
  • AbbVie Inc.
  • ACIC Pharmaceuticals Inc.
  • Adimmune Corporation
  • Ajinomoto Bio-Pharma Services
  • Albemarle Corporation
  • Alembic Ltd
  • Alkem laboratories Ltd.
  • Almac Group
  • Alven Laboratories S.r.o.
  • Ambio Pharma Inc.
  • Amneal Pharmaceuticals Inc.
  • Apicore LLC
  • Aragen Life Sciences (GVK Biosciences Private Limited)
  • Arene Lifesciences Limited.
  • AstraZeneca plc
  • Aurobindo Pharma
  • Ampac fine chemicals LLC
  • Axplora
  • BASF SE
  • Bayer AG
  • Bachem holding AG
  • Bal Pharma Ltd.
  • Biocon Limited
  • Biogen Inc.
  • Biomarin Pharmaceutical Inc
  • Biophore India Pharmaceuticals Pvt. Ltd.
  • Biosortia Pharmaceuticals Inc.
  • Biotechnica Pharma Global
  • Blanver
  • Boehringer Ingelheim GmbH
  • Brawn Biotech Ltd.
  • Bristol-Myers Squibb Company
  • Cadila Pharmaceuticals Limited
  • Curia
  • Catalent, Inc.
  • Cayman Chemicals
  • Celltrion Inc.,
  • Cambrex Corporation
  • Century Pharmaceuticals Ltd
  • CFM Group (AMSA S.P.A)
  • Changzhou Pharmaceutical Factory
  • ChemCon GmbH
  • China Chemical & Pharmaceutical Co., Ltd.
  • Chongqing Huapont Pharmaceutical CO LTD,
  • Cipla Limited
  • CKD Bio
  • Corden Pharma International (Germany)
  • CSL Ltd
  • Daiichi Sankyo Chemical Pharma Co Ltd
  • Daito Pharmaceutical Co., Ltd
  • Dishman Carbogen Amcis
  • Dr.Reddy’s Laboratories
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Emcure Pharmaceuticals Ltd.
  • Ercros S.A.
  • Estechpharma Co., Ltd.
  • Esteve Quimica SA
  • Everest Organics Limited
  • Evonik Industries AG
  • F. Hoffmann-La Roche AG
  • Fareva Group
  • FIS Fabbrica Italiana Sintetici SPA
  • Flamma S.p.A
  • Formosa Laboratories, Inc.
  • Fuji Chemical Industry Co.,Ltd
  • Gentec Pharmaceutical Group S.A (DUKE CHEM and PHARMANOID)
  • Gilead Sciences, Inc.
  • Givaudan (Indena)
  • Gland Pharma Limited
  • GlaxoSmithKline plc
  • Glenmark Pharmaceutical Ltd.
  • GRANULES INDIA LTD.
  • Grupo Ferrer Internacional S.A (Interquim, S.A)
  • Harman Finochem Limited.
  • Heraeus Holding GmbH
  • Hetero Labs Ltd.
  • Hikma pharmaceuticals
  • Hybio Pharmaceutical Co., Ltd.
  • Hikal Ltd.
  • Ibio Inc
  • Inabata Co. Ltd.
  • INTAS PHARMACEUTICALS LTD,
  • Jeil Pharmaceutical Co. Ltd.,
  • Johnson and Johnson
  • Johnson Matthey Pharma Services Inc.
  • Jubilant lifesciences (Jubilant generics Ltd)
  • Katsura Chemical Co.,Ltd.
  • Kern Pharma, S.L.,
  • Kleos pharma
  • Kocak Farma Pharmaceutical
  • Kosher Pharmaceuticals
  • Krka, tovarna zdravil, d. d., Novo mesto
  • Kyowa Hakko Kirin
  • Laboratorium ofichem bv
  • Lannett Company Inc.
  • Laurus Labs
  • Lebsa
  • Lonza group
  • Lusochimica S.p.A
  • LOTUS Pharmaceutical Co., Ltd.
  • Lesaffre (Gnosis S.p.A.)
  • Magle Chemoswed AB
  • Mallinckrodt Pharmaceuticals
  • Medichem S.A
  • Megafine Pharma Ltd
  • Mehta API
  • Merck KGaA
  • Metrochem API
  • Micro Labs LTD
  • Minakem High Potent S.A.
  • Moehs Iberica SL
  • Molcan
  • Morepen
  • MSN Organics Pvt, Ltd.
  • Natco Pharma
  • Neuland laboratories Ltd.
  • Novartis International AG
  • Novo Holdings A/S
  • Olainfarm JSC
  • OLON S.P.A.
  • Orchid Chemicals & Pharmaceuticals Ltd
  • Orion (Fermion)
  • Optimus Drugs Private LTD.
  • Paratek Pharmaceuticals, Inc.
  • Perrigo Company plc,
  • Pfizer Inc.
  • Phyton Biotech LLC
  • Pierre Fabre
  • Polpharma
  • Prajna Generics Pvt. Ltd.
  • Protex International (ICROM S.p.A.)
  • Rablon Healthcare Pvt Ltd
  • Saneca Pharmaceuticals a.s.
  • Sanofi S.A.
  • Solara Active Pharma
  • Seikagaku Corporation
  • SEQUENS (Wavelength Pharmaceuticals)
  • Shiono Chemical Co., Ltd.
  • SM BIOMED SDN. BHD
  • Siegfried Holding AG
  • Standard Chemical & Pharmaceutical Co.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Syn-tech chem. And Pharma.Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • Temad Co.
  • Teva Pharmaceutical industries Ltd.
  • Umicore
  • Unichem Laboratories LTD.
  • Union Quimico Farmaceutica, S.A. UQUIFA,
  • Venus Remedies Limited
  • Vertex Pharmaceuticals Inc.

For more information about this report visit https://www.researchandmarkets.com/r/twt43d

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Overseas Expansion Strategy of K-OTT Introduced in France, KOCCA holds the ‘2024 Korea-France Content Forum’

Published

on

overseas-expansion-strategy-of-k-ott-introduced-in-france,-kocca-holds-the-‘2024-korea-france-content-forum’

– The ‘Korea-France Content Forum’ held to establish the Foundation for K-OTT’s oversea expansion
PARIS, May 24, 2024 /PRNewswire/ — The Ministry of Culture, Sports and Tourism (Minister Yu In-chon) and the Korea Creative Content Agency (President, Jo Hyun-rae, hereafter KOCCA) held the ‘2024 Korea-France Content Forum’ on May 24th during the Korea Expo in Paris, France.

The ‘2024 Korea-France Content Forum’ featured a keynote session (K-OTT’s Strategies in Global market) presenting K-OTT’s strategies for international expansion and a roundtable session (Strategies in the Era of Streaming) discussing the growth of OTT platforms and collaborative approaches with production companies.
The forum featured participation from various industry leaders including Kun hee Park (CEO, Wavve Americas), Sangjin Lee (Head of content IP Business, LG U+), Seung ae Sohn (Executive Director, Showbox), Ji ae Sohn (Ambassador for Cultural Cooperation), Moonju Kim (General Director, France Business Center, KOCCA), Isabelle Degeorges (President, Gaumont Television France) which produced the French Netflix original series, participated.
Strategy announcement by Wavve Americas (KOCAWA), the first K-OTT’s launched in Europe
During the Keynote Session, Park Kun Hee – CEO of Wavve Americas, the first domestic OTT Platform to launch services in Europe, Took the stage to discuss the international expansion strategy of KOCOWA, which started offering services in 39 countries including Europe since April of this year. Following this, Lee Sangjin, Head of Content IP Business of LG U+, presented the expansion strategy of LG U+ Mobile TV, encompassing diverse original content.
During the round-table session, participants shared thoughts and solutions regarding the survival strategies of local OTT platforms and production companies amidst the rapid waves of change brought about by the emergence of global OTT platforms.
In particular, through this forum, we were able to observe the proactive implementation of IP protection policies by local production companies in France, aimed at sustainable content creation. Isabelle Degeorges, CEO of Gaumont Television France, noted, “With the introduction of the European Audiovisual Media Services Directive (AVMSD), platforms and production companies can share IPs three years after supplying the content.” Kim Moon-joo, Director of the Korea Creative Content Agency’s France Business Center, participated as a panelist, introducing policies aimed at enhancing the competitiveness of K-OTT and fostering collaboration with production companies.
Park Kun Hee, CEO of Wavve Americas, who participated in the event, stated, “It was a meaningful opportunity to introduce our platform locally in Europe in line with KOCOWA’s expansion into the region”. Additionally, Kyoungbon Koo, Director Broadcasting & Video Content Division at KOCCA commented, “It was a meaningful occasion to not only introduce K-OTT’s strategies to Europe but also to exchange ideas on collaboration between Korea and France. We will continue to focus on activating various forms of collaboration with major international partners in the future”.
KOCCA supports the overseas expansion of excellent domestic OTT content and platforms through the newly established Local OTT Specialized Support Program this year. This initiative aims to enhance the competitiveness of domestic OTT platforms and content by adapting to the changing industrial environment.
Photo – https://mma.prnewswire.com/media/2421769/Korea_France_Content_Forum_Photo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/overseas-expansion-strategy-of-k-ott-introduced-in-france-kocca-holds-the-2024-korea-france-content-forum-302155362.html

Continue Reading

Artificial Intelligence

IoT Node and Gateway Market worth $604.7 billion by 2029 – Exclusive Report by MarketsandMarkets™

Published

on

iot-node-and-gateway-market-worth-$604.7-billion-by-2029-–-exclusive-report-by-marketsandmarkets™

CHICAGO, May 24, 2024 /PRNewswire/ — The IoT Node and Gateway market is projected to grow from USD 424.6 billion in 2024 and is estimated to reach USD 604.7 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of the IoT Node and Gateway market is driven by the Provision of increased IP address space through IPv6, Emergence of 5G technology, and Increasing need for data centers.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248007097
Browse in-depth TOC on “IoT Node and Gateway Market”
410 – Tables70 – Figures390 – Pages
IoT Node and Gateway Market Report Scope:
Report Coverage
Details
Market Revenue in 2024
$ 424.6 billion
Estimated Value by 2029
$ 604.7 billion
Growth Rate
Poised to grow at a CAGR of 7.3%
Market Size Available for
2020–2029
Forecast Period
2024–2029
Forecast Units
Value (USD Million/Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
By Hardware, End-use Application and Region
Geographies Covered
North America, Europe, Asia Pacific, and Rest of World
Key Market Challenge
Requirement for wireless spectrum and licensed spectrum
Key Market Opportunities
Accelerated IoT adoption in healthcare sector
Key Market Drivers
Rising use of wireless smart sensors and networks
By Hardware, the Logic Devices are projected to grow at a high CAGR of IoT Node and Gateway market during the forecast period.
Logic devices can adapt to changing requirements even after deployment. As new features or functionalities are needed, the logic within the device can be reprogrammed to accommodate these changes, extending the useful life of the product and reducing the need for hardware revisions. The integration of FPGA technology into IoT devices further enhances these advantages. The integration of FPGAs into IoT nodes and gateways empowers manufacturers to develop highly optimized, customizable, and scalable solutions that meet the diverse needs of IoT applications. Tesla’s Full Self-Driving (FSD) computer utilizes FPGAs to handle complex neural network computations for autonomous driving algorithms. This allows them to potentially improve their FSD capabilities through software updates that reconfigure the logic within the FPGAs.
BFSI segment in IoT Node and Gateway Market is projected to grow at a highest CAGR during the forecast period.
BFSI sector can use IoT technology to provide more convenient solutions for customers. IoT can be used to perform data collection in real time and for instant communication between devices. For instance, it can facilitate cashless payments using an RFID scanner to identify products in the shopping cart and mobile wallet. The adoption of mobile point of sale (mPOS) systems and kiosks is fundamentally reshaping the landscape of the BFSI market. mPOS facilitates transactions anytime, anywhere, benefiting unbanked populations and enabling temporary service points for events. Kiosks offer convenient banking functionalities, reducing wait times and freeing up staff for complex inquiries. These technologies drive cost savings by requiring less investment and automating routine tasks, allowing resources to be reallocated strategically. They provide rich data for personalized services, fraud detection, and operational optimization. mPOS systems and kiosks promote financial inclusion by extending services to remote areas, fostering economic activity and well-being.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=248007097
North America accounts for the largest share in IoT Node and Gateway Industry.
The North American IoT market is poised to grow, driven by government efforts to transition cities into smart urban centers. The growing need for sophisticated IoT solutions, fueled by the widespread availability of high-speed data, will further propel market expansion in this region. Furthermore, North America’s dynamic IoT node and gateway ecosystem features established players like Intel Corporation (US), Texas Instruments Incorporated (US), Dell (US), and Cisco Systems (US), driving competition, innovation, and affordability. Increasing research and development at industry levels is broadening the application areas of IoT in various industries, such as retail, consumer electronics, automotive and transportation, and healthcare, especially in the US. The increased demand for effective solutions and focus on early, accurate, and fast diagnosis of diseases has led to huge investments in technological developments in the healthcare sector.
Key Players
Key companies operating in the IoT Node and Gateway companies are Intel Corporation (US), Qualcomm Technologies, Inc. (US), Texas Instruments Incorporated (US), STMicroelectronics (Switzerland), Microchip Technology Inc. (US), Huawei Technologies Co., Ltd. (China), NXP Semiconductors N.V. (Netherlands), Cisco Systems, Inc. (US), Hewlett Packard Enterprise Development LP (US), TE Connectivity Ltd (Switzerland), Advantech Co., Ltd. (Taiwan), Dell Technologies (US), among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=248007097
Browse Adjacent Market: Semiconductor and Electronics Market Research Reports &Consulting
Related Reports: 
IoT Technology Market by Node Component (Sensor, Memory Device, Connectivity IC, Processor, Logic Devices), Software Solution (Remote Monitoring, Data Management), Platform, Service, End-use Application, Geography – Global Forecast to 2029
Industrial IoT Market Size, Share & Industry Growth Analysis Report by Device & Technology, Connectivity Type, Software, Vertical (Manufacturing, Energy, Oil & Gas, Healthcare, Retail, Transportation, Metals & Mining, Agriculture), and Geography – Global Growth Driver and Industry Forecast to 2026
Internet of Robotic Things Market (IoRT) by Component (Sensor, Power, Control), Service (Professional, Managed), Platform (Device, Application, Network), Software (Analytics, Data, Security, Monitoring, Bandwidth), Application – Global Forecast to 2022
MulteFire Market by Device (Small Cells, Switches, Controllers), Application (Industrial Manufacturing, Commercial, Transportation, Public Venues, Healthcare, Oil & Gas and Mining, Power Generation, Hospitality), and Geography – Global forecast 2025
Smart Robots Market Size, Share by Component (Sensors, Actuators, Control Systems), Type, Operating Environment, Mobility, Application (Domestic, Field/Agricultural, Public Relations, Industrial), and Region – Global Forecast to 2025
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact: Mr. Aashish MehraMarketsandMarkets™ INC. 630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Our Web Site: https://www.marketsandmarkets.com/Research Insight: https://www.marketsandmarkets.com/ResearchInsight/iot-gateway-market.aspContent Source: https://www.marketsandmarkets.com/PressReleases/iot-gateway.asp
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/iot-node-and-gateway-market-worth-604-7-billion-by-2029—exclusive-report-by-marketsandmarkets-302155034.html

Continue Reading

Artificial Intelligence

atNorth Wins ‘Colocation Provider of the Year’ and ‘Digital Infrastructure Project of the Year’ at Industry Award Events

Published

on

atnorth-wins-‘colocation-provider-of-the-year’-and-‘digital-infrastructure-project-of-the-year’-at-industry-award-events

AtNorth recognized at the Electrical Review & Data Centre Review Awards and the Tech Capital Awards.
REYKJAVÍK, Iceland, May 24, 2024 /PRNewswire/ — atNorth, the leading Nordic colocation, high-performance computing, and artificial intelligence service provider has today announced further acknowledgement in the industry as it wins two significant awards.

The business has been awarded the `Colocation Provider of the Year’ award at the Electrical Review & Data Centre Review Awards. atNorth has undertaken a significant expansion strategy in recent years, that has ensured that the business can offer high performance infrastructure at speed and scale. This award reflects the business’ growth journey as it continues to innovate and adapt to technological advancements and client requirements.
atNorth has also won the `Digital Infrastructure Project of the Year’ at the Tech Capital Awards for its work with client, Shearwater Geoservices.  The global marine imaging and processing leader achieved a 92% reduction in CO2 output and an 85% reduction in cost by moving a portion of its UK HPC infrastructure to one of atNorth’s Icelandic data center sites.
Fueled by the abundant renewable power sources of the Nordics, atNorth`s services deliver performance and efficiency for high density workloads in a sustainable way that enables clients to decarbonize their IT footprint and reduce overall costs.
Winners are voted for by a panel of industry experts for both awarding bodies in a process that aims to recognize the outstanding achievements within the digital infrastructure industry.
“We are thrilled to receive these acknowledgments for our data center services”, says Eyjólfur Magnús Kristinsson, CEO at atNorth. “atNorth has experienced significant growth over the last couple of years and this industry recognition is a testament to our dedication to delivering excellence across the board. We are determined to continue decarbonizing the world’s most demanding workloads in an efficient, sustainable, and cost-effective way.”
The news follows atNorth’s announcements of colocation clients Crusoe, BNP Paribas and Advania. The business has also received recent recognition from multiple other awarding bodies including; the Datacloud Global Awards, the Energy Awards, TechRound’s Sustainability60 and the UK Green Business Awards.  
About atNorth
atNorth is a leading Nordic data center services company that offers sustainable, cost-effective, scalable colocation and high-performance computing services trusted by industry-leading organizations. The business acquired leading High-Performance Computing (HPC) provider, Gompute, in 2023 enabling a compelling full stack offering tailored to AI and other critical high-performance workloads. 
With sustainability at its core, atNorth’s data centers run on renewable energy resources and support circular economy principles. All atNorth sites leverage innovative design, power efficiency, and intelligent operations to provide long-term infrastructure and flexible colocation deployments. The tailor-made solutions enable businesses to calculate, simulate, train and visualize data workloads in an efficient, cost-optimized way.
atNorth is headquartered in Reykjavik, Iceland and operates seven data centers in strategic locations across the Nordics, with additional sites to open in Helsinki, Finland and in Denmark in Q4 2024, as well as its tenth site ready for operation in Kouvola, Finland in 2025.
For more information, visit atNorth.com or follow atNorth on LinkedIn or Facebook.
Press Contact:Caroline BruntonKite Hill PR for atNorth+44 (0) 7796 274 [email protected]
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/atnorth/r/atnorth-wins–colocation-provider-of-the-year–and–digital-infrastructure-project-of-the-year–at-i,c3987735
The following files are available for download:
https://mb.cision.com/Main/18907/3987735/2820097.pdf
Release
https://news.cision.com/atnorth/i/awards,c3303761
Awards
https://news.cision.com/atnorth/i/ice03-02227-front-left-close,c3303762
ICE03 02227 front left close
 

View original content:https://www.prnewswire.co.uk/news-releases/atnorth-wins-colocation-provider-of-the-year-and-digital-infrastructure-project-of-the-year-at-industry-award-events-302155172.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending